192 results
6-K
EX-99
BLRX
Bioline Rx Ltd
17 Apr 23
BioLineRx Announces Publication in Nature Medicine of its GENESIS Phase 3 Clinical Trial Data Evaluating
11:08am
Exhibit 1
BioLineRx Announces Publication in Nature Medicine of its GENESIS Phase 3 Clinical Trial Data Evaluating
Motixafortide and G-CSF in Stem … primary
and secondary endpoints -
- Nature Medicine publication describes how GENESIS trial included patients representative of current multiple
6-K
EX-99
BLRX
Bioline Rx Ltd
27 May 20
BioLineRx Announces Publication of Data from Ongoing
7:00am
Exhibit 1
For Immediate Release
BioLineRx Announces Publication of Data from Ongoing
COMBAT/KEYNOTE-202 Clinical Trial
in Nature Medicine
Tel … published in the peer-reviewed journal Nature Medicine.
The paper highlights previously disclosed biomarker and clinical data from the Company’s ongoing
6-K
EX-99
BLRX
Bioline Rx Ltd
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
) -
- Rapidly Advancing U.S. Commercial Activities in Support of Potential September Launch -
- Announced Publication in Nature Medicine of GENESIS … of motixafortide in September of this year,” said Philip Serlin, Chief Executive Officer of BioLineRx. “Last month’s publication in Nature Medicine of our
6-K
EX-99
BLRX
Bioline Rx Ltd
5 Apr 12
2012 Annual General Meeting of Shareholders
12:00am
of Directors to fix the compensation of said auditors in accordance with the amount and nature of their services.
TO VOTE ON THE PROPOSAL TO APPROVE … in accordance with the volume and nature of their services to the Company.
In compliance with the Companies Law, our Board of Directors will present
6-K
EX-99
BLRX
Bioline Rx Ltd
10 Jul 13
2013 Annual General Meeting of Shareholders
12:00am
, 2013 and to authorize the Audit Committee of the Board of Directors to fix the compensation of said auditors in accordance with the scope and nature … , the risk management policy of the Company; (iii) the size of the Company and the nature of its operations; and (iv) in connection with the terms of service
6-K
EX-99
ir0m7d ck5199t
27 Oct 21
2021 Annual General Meeting of Shareholders
5:05pm
6-K
9si29qr0b drq
22 Sep 14
Current report (foreign)
12:00am
6-K
EX-99
kw0lz otcew
5 Apr 12
2012 Annual General Meeting of Shareholders
12:00am
6-K
EX-2
aph2hcbc
27 Oct 21
2021 Annual General Meeting of Shareholders
5:05pm
6-K
8gf8kjl81tk
3 Dec 21
Current report (foreign)
4:30pm
6-K
EX-2
xy1mwm7i
13 Oct 11
Current report (foreign)
12:00am
6-K
zfdqo 3ct4kneko4virk
15 Aug 13
Current report (foreign)
12:00am
6-K
EX-99
0d9tbrs28en
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
6-K
n9jm226m0d6i65ddy5s
8 Aug 23
Current report (foreign)
5:25pm
6-K
qq4iy0ykll
21 Nov 11
Current report (foreign)
12:00am
6-K
etz58nqq
15 May 12
Current report (foreign)
12:00am
6-K
EX-99
wql1pmvz 30oiq
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
6-K
EX-3
h1471ehxpj9 tzyu
27 Oct 21
2021 Annual General Meeting of Shareholders
5:05pm
6-K
9p6skp
24 Sep 20
Current report (foreign)
4:30pm
6-K
EX-99
54aojta6e8o6sk
10 Jul 13
2013 Annual General Meeting of Shareholders
12:00am